🇺🇸 FDA
Pipeline program

Experimental vaccine

PRO-msIPV-3001

Phase 3 mab completed

Quick answer

Experimental vaccine for Poliomyelitis is a Phase 3 program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
SINOVAC BIOTECH LTD
Indication
Poliomyelitis
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials